Skip to content
UHS

Universal Health Services, Inc.

Universal Health Services, Inc. Q4 FY2025 earnings call

February 26, 2026 · fiscal period ended 2025-12

EPS · actual vs est

$5.88 / $5.92Miss -0.7%

Revenue · actual vs est

$4.49B / $4.51BMiss -0.5%
Ask about this call

Summary

Generated 2026-02-26

Management highlights

• Growth Agenda: Opened two new acute care hospitals, laid groundwork for new capacities in 2026; in behavioral segment, focused on outpatient strategy with 119 outpatient locations, on track to open 10 more in 2026. • Expense Management: Acute care margins improved due to reduced contract labor and strong supply chain; behavioral margins stable with staffing investments. • Technology: Deployed AI in operations for quality/patient experience and administrative operations for efficiency; rolled out agentic AI for post-discharge care, and plans to roll out more in 2026.

View in transcript ↓

Segment performance

Acute Care Segment: Fourth quarter same facility net revenues increased 6.9% reported, 5.2% excluding insurance subsidiary; same facility revenue per adjusted admission increased 5.4%; segment EBITDA grew 10.4% with margin at 14.8% for Q4, full year margin improved 150 basis points to 15.8%. Behavioral Health Segment: Fourth quarter same facility net revenues increased 7.2%, supported by 5.6% revenue per adjusted patient day and 1.5% adjusted patient days; expenses increased slightly faster than revenue due to headcount growth; segment EBITDA grew 6.9% in Q4 and 7.8% for full year 2025.

View in transcript ↓

Guidance

• Revenue expected to range 18.4 - 18.8 billion, growth 6 - 8%. • Adjusted EBITDA net of NCI expected 2.64 - 2.79 billion, growth 2 - 8%. • Adjusted net income attributable to UHS per diluted share 22.64 - 24.52, growth 4 - 13%. • Assumes 2 - 3% same facility volume growth for both segments in 2026, but first quarter likely below due to winter storms. • Capital expenditures 950 million - 1.1 billion. • Assumes adverse impact from health insurance exchanges, California behavioral staffing regulations, and includes net benefit from Medicaid supplemental payments and other items.

View in transcript ↓

Risks

• Health insurance exchange volumes decline could lead to bad debt risk. • California behavioral staffing regulations may increase labor costs and cause short-term volume disruption. • Uncertainty around Medicaid work requirements and funding cuts impact. • Timing issues with receivables related to new programs.

View in transcript ↓

Q&A highlights

Q: Drill down on 2026 guidance volume growth, pricing; A: Acute pricing 3 - 4% increase, behavioral 2 - 3% with pricing moderation.

Q: How AI translates to operating performance; A: AI used in administrative efforts like revenue cycle, post-discharge, driving efficiencies.

Q: Acute care volumes, surgical vs medical; A: Surgical volume positive in 2025, expected similar in 2026; Nevada market had challenges in 2025 but expected uptick in 2026.

Q: Exchange volumes, bad debt; A: Expect 25 - 30% decline, already seeing decline, risk of bad debt.

Q: California behavioral staffing headwind; A: Need to change staffing mix to licensed professionals, upfront costs, but ongoing impact lower after full staffing.

Q: Outpatient behavioral demand, mix; A: Outpatient represents 10% of revenue, expected to grow, offering various services, outpatient margins better.

Q: California staffing, reimbursement; A: Staffing mix change, need to work with payers for reimbursement.

Q: Behavioral margin expansion; A: Revenue growth likely exceed cost increase, outpatient growth helps.

Q: Acute length of stay, AI; A: Acuity-adjusted LOS below pre-pandemic, supply of sub-acute capacity a hurdle.

Q: Medicaid supplementals, approval; A: Florida program expected approval, California more uncertain.

Q: Leverage ratio; A: Aim for 2 - 3 ratio, keep flexibility for opportunities, continue share repurchase.

Q: AI examples, efficiencies; A: Used in post-discharge, rounding, intake, hard to pinpoint exact dollars but promising.

Q: Behavioral volume confidence; A: Sequential improvement in 2025, investments give confidence for 2026 target.

Q: Healthcare policy risk, Medicaid; A: Uncertainty around Medicaid work requirements, impact hard to quantify.

Q: Cash flow, supply trends; A: Cash flow historically 75 - 80% of operating income; supply costs well controlled.

Q: Behavioral pricing, Medicaid volume; A: DPP reimbursement to reduce in 2028, use outpatient growth as hedge.

Q: Behavioral FTE growth, volume outlook; A: Staffing challenges vary by market, hiring in key areas gives confidence for 2026 volume target

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$5.88$5.92-0.7%
Revenue$4.49B$4.51B-0.5%

Transcript

February 26, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.